Sadler Jason D
Known title: Pres., International MarketsCIK: 0001554974
Associated companies
Transaction History
| CI | ▲ Buy | Grant | 5,070 | $0 | 2/24/2023 | View on chart |
| CI | ▲ Buy | Grant | 1,693 | $0 | 2/22/2023 | View on chart |
| CI | ▲ Buy | Option Exercise | 2,490 | $491K | 12/9/2022 | View on chart |
| CI | ▲ Buy | Option Exercise | 2,012 | $369K | 12/9/2022 | View on chart |
| CI | ▲ Buy | Option Exercise | 6,886 | $1.3M | 12/8/2022 | View on chart |
| CI | ▼ Sell | Open Market | 6,886 | $2.3M | 12/8/2022 | View on chart |
| CI | ▲ Buy | Option Exercise | 9,781 | $1.9M | 12/8/2022 | View on chart |
| CI | ▼ Sell | Open Market | 9,781 | $3.3M | 12/8/2022 | View on chart |
| CI | ▲ Buy | Option Exercise | 2,897 | $432K | 7/11/2022 | View on chart |
| CI | ▲ Buy | Option Exercise | 9,505 | $1.4M | 7/8/2022 | View on chart |
| CI | ▼ Sell | Open Market | 9,505 | $2.7M | 7/8/2022 | View on chart |
| CI | ▲ Buy | Option Exercise | 1,104 | $154K | 6/29/2022 | View on chart |
| CI | ▼ Sell | Open Market | 3,458 | $934K | 6/28/2022 | View on chart |
| CI | ▲ Buy | Option Exercise | 3,458 | $481K | 6/28/2022 | View on chart |
| CI | ▼ Sell | Open Market | 5,000 | $1.3M | 4/6/2022 | View on chart |
| CI | ▲ Buy | Grant | 2,628 | $0 | 2/25/2022 | View on chart |
| CI | ▲ Buy | Grant | 2,093 | $0 | 2/23/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Cigna Focuses on Data-Driven Care and Valuation Metrics
Recent coverage highlights Cigna's strategic shift toward data-driven care through its Health Sense initiative, positioning it as a key differentiator in the healthcare sector. Analysts are also examining the stock's valuation, noting a forward P/E that suggests value despite ongoing earnings risks. With the stock trading near its 52-week high, these developments provide context for its current market position relative to peers like UnitedHealth.
Cigna Focuses on Data-Driven Care and Valuation Metrics. Recent coverage highlights Cigna's strategic shift toward data-driven care through its Health Sense initiative, positioning it as a key differentiator in the healthcare sector. Analysts are also examining the stock's valuation, noting a forward P/E that suggests value despite ongoing earnings risks. With the stock trading near its 52-week high, these developments provide context for its current market position relative to peers like UnitedHealth.